卖什么
推动化学品生产现代化。
商业模式拆解
买家：谁掌握预算？
Process development / R&D leaders at pharmaceutical, agrochemical and specialty chemical companies (e.g. AstraZeneca retrospective case).
触发点：什么让他们现在购买？
One reaction holding up a programme, or a need for solvent replacement and scale-up kinetics faster than months of lab work.
工作流：什么输入变成什么输出？
Runs reactions in an automated lab, delivers FAIR data via download or API, and fits kinetic models to scale up right first time.
经济账：省了什么，怎么收费？
Sells data and insights; claims data in days vs months and kinetic modeling over 50x faster.
渠道：怎么接触到客户？
'Get in touch' contact-led; case studies.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-01-28 | — | £4M | — | news.google.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.